Literature DB >> 16625791

Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.

Anna M Chiarelli1, Verna Mai, Erika E Halapy, Rene S Shumak, Frances P O'Malley, Neil S Klar.   

Abstract

BACKGROUND: The effect of severity of screening result on delays to diagnosis has primarily been examined for mammographic abnormalities. This study will examine delays to assessment and diagnosis for women with an abnormal mammogram compared to women with an abnormal clinical breast examination (CBE) or abnormal CBE and mammogram.
METHODS: Using data routinely collected by Ontario Breast Screening Program (OBSP), 12,675 women aged 50 to 69 with an abnormal screening result between January 1, 2000 and December 31, 2000 were followed prospectively to the completion of their assessment process. Median waiting times from abnormal screen to first assessment procedure and diagnosis were compared by modality of referral and among women with a breast cancer diagnosis by prognostic features.
RESULTS: The median waiting time to first assessment and to diagnosis was significantly longer for women with only a clinical abnormality compared to women with a mammographic abnormality. In addition, women diagnosed with cancers of larger size had longer delays when the abnormality was detected only clinically. However, women referred by both modalities had significantly shorter waiting times to first assessment procedure and to diagnosis of poor prognosis cancers compared to women referred by mammography alone.
INTERPRETATION: Women with an abnormal CBE and mammogram are assessed more promptly and have shorter diagnostic times. However, women with only a CBE abnormality had delays to diagnosis as a result of longer waiting times to first assessment procedure. Integration of the OBSP with assessment centres should improve times to diagnosis irrespective of modality of referral.

Entities:  

Mesh:

Year:  2005        PMID: 16625791      PMCID: PMC6976148     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  17 in total

1.  Organized breast cancer screening programs in Canada.

Authors:  A B Miller
Journal:  CMAJ       Date:  2000-10-31       Impact factor: 8.262

2.  Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995.

Authors:  L S Caplan; D S May; L C Richardson
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

Review 3.  The psychosocial consequences of mammography.

Authors:  B K Rimer; L G Bluman
Journal:  J Natl Cancer Inst Monogr       Date:  1997

4.  Reducing deaths from breast cancer in Canada. The Workshop Group.

Authors: 
Journal:  CMAJ       Date:  1989-08-01       Impact factor: 8.262

5.  Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.

Authors:  Ivo A Olivotto; Asako Gomi; Christina Bancej; Jacques Brisson; Jon Tonita; Lisa Kan; Zeva Mah; Marion Harrison; Rene Shumak
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

6.  Factors associated with adequacy of diagnostic workup after abnormal breast cancer screening results.

Authors:  M Schootman; J Myers-Geadelmann; L Fuortes
Journal:  J Am Board Fam Pract       Date:  2000 Mar-Apr

7.  Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Mark Helfand; Benjamin K S Chan; Steven H Woolf
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

8.  Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma.

Authors:  O Ganry; J Peng; A Dubreuil
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

9.  Patient navigation: improving timeliness in the diagnosis of breast abnormalities.

Authors:  Brian J Psooy; Dianna Schreuer; Joy Borgaonkar; Judy S Caines
Journal:  Can Assoc Radiol J       Date:  2004-06       Impact factor: 2.248

10.  Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.

Authors:  L E M Duijm; J H Groenewoud; F H Jansen; J Fracheboud; M van Beek; H J de Koning
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

View more
  6 in total

1.  Timeliness of follow-up after abnormal screening mammogram: variability of facilities.

Authors:  Robert D Rosenberg; Sebastien J P A Haneuse; Berta M Geller; Diana S M Buist; Diana L Miglioretti; R James Brenner; Rebecca Smith-Bindman; Stephen H Taplin
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

2.  Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography.

Authors:  Danielle D Durham; Whitney R Robinson; Sheila S Lee; Stephanie B Wheeler; Katherine E Reeder-Hayes; J Michael Bowling; Andrew F Olshan; Louise M Henderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11       Impact factor: 4.254

3.  Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005.

Authors:  Lisa C Richardson; Janet Royalty; William Howe; William Helsel; William Kammerer; Vicki B Benard
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

4.  Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.

Authors:  Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-10       Impact factor: 3.240

5.  Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients.

Authors:  L Jiang; J Gilbert; H Langley; R Moineddin; P A Groome
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

6.  Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method.

Authors:  Amalia Plotogea; Anna M Chiarelli; Lucia Mirea; Maegan V Prummel; Nelson Chong; Rene S Shumak; Frances P O'Malley; Claire Mb Holloway
Journal:  Springerplus       Date:  2014-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.